Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > from your own link:

<< Previous

Bullboard Posts

Next >>

Comment by GunnerGon Aug 26, 2020 10:18am

80 Views

Post# 31454933

RE:from your own link:

Instead of reposting the same garbage 10 times a day why not try a stay current.

The head of the FDA has pulled that statement back already.

Click Here for a google search.

realstocky wrote:
The FDA said people under the age of 80 who were not on a respirator and received plasma containing high levels of antibodies had a 35% better survival rate a month after the treatment than those who had received plasma with a low level of antibodies

=================================================================

35% is huge in terms of efficacity